Keeping public institutions invested in tobacco

Journal of Business Ethics 73 (2):161 - 176 (2007)
Increasingly through the 1990s, tobacco control advocates questioned the practice of public institutions investing in tobacco company stocks. The questioning was framed in at least three ways. First, is it ethical to fund public expenditures with profits from a product that causes addiction and disease? Second, is it sound social policy to derive public income from a product that increases healthcare costs and reduces worker productivity? Finally, is it sound fiscal policy to invest in an historically profitable industry facing multiplying legal and regulatory challenges? While the tobacco industry preferred to restrict discussion to the fiscal question, and offered an affirmative answer, its position was weakened by depressed stock prices brought on by actions of the industry as much as by tobacco control activism. As part of a campaign to restore its credibility as an investment vehicle with public fund managers, Philip Morris (PM) commissioned a report from the influential investment managers/advisors Wilshire Associates. However, Wilshire had only recently conducted such a study for the Washington State Investment Board (WSIB), assuring the board that the value tobacco stocks added to an investment portfolio – if any – was too small to be measured. Nonetheless, within a year, Wilshire produced a report for PM which appeared to laud the investment value of tobacco and to dismiss tobacco-excluded investment alternatives. This paper examines how Wilshire produced apparently diametrically opposed reports for clients with different interests. It reveals a pattern of potential conflicts of interest among tobacco companies, financial analysis firms, investment authorities, and institutional fund managers. It demonstrates substantial violations of two generally accepted ethical principles of business consulting: veracity and transparency.
Keywords divestment  ethics  consulting  public health policy  public investments  tobacco industry documents
Categories (categorize this paper)
DOI 10.2307/25075410
 Save to my reading list
Follow the author(s)
My bibliography
Export citation
Find it on Scholar
Edit this record
Mark as duplicate
Revision history Request removal from index
Download options
PhilPapers Archive

Upload a copy of this paper     Check publisher's policy on self-archival     Papers currently archived: 15,831
External links
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library
References found in this work BETA
Derek Yach (2001). Healthy Investments in Investing in Health. Journal of Business Ethics 33 (3):191 - 198.

Add more references

Citations of this work BETA

No citations found.

Add more citations

Similar books and articles
Mark S. Schwartz (2003). The "Ethics" of Ethical Investing. Journal of Business Ethics 43 (3):195 - 213.
Derek Yach (2001). Healthy Investments in Investing in Health. Journal of Business Ethics 33 (3):191 - 198.

Monthly downloads

Added to index


Total downloads

7 ( #291,535 of 1,724,865 )

Recent downloads (6 months)

3 ( #210,938 of 1,724,865 )

How can I increase my downloads?

My notes
Sign in to use this feature

Start a new thread
There  are no threads in this forum
Nothing in this forum yet.